| 000 | 01524 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513031809.0 | ||
| 264 | 0 | _c19950817 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0012-3692 | ||
| 024 | 7 |
_a10.1378/chest.108.1.163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWieskopf, B | |
| 245 | 0 | 0 |
_aCyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. _h[electronic resource] |
| 260 |
_bChest _cJul 1995 |
||
| 300 |
_a163-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoradiometric Assay |
| 650 | 0 | 4 |
_aKeratins _xblood |
| 650 | 0 | 4 |
_aLung Diseases _xblood |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aDemangeat, C | |
| 700 | 1 | _aPurohit, A | |
| 700 | 1 | _aStenger, R | |
| 700 | 1 | _aGries, P | |
| 700 | 1 | _aKreisman, H | |
| 700 | 1 | _aQuoix, E | |
| 773 | 0 |
_tChest _gvol. 108 _gno. 1 _gp. 163-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.108.1.163 _zAvailable from publisher's website |
| 999 |
_c7541200 _d7541200 |
||